Myfortic and Leukopenia

The anti-rejection drug Myfortic® (mycophenolate sodium) has been studied thoroughly in clinical trials. In these studies, the side effects that occurred in a group of people taking Myfortic were documented and then compared to those that occurred in a similar group of people taking another anti-rejection medicine.
 
In these trials, leukopenia (decreased white blood cell counts) was reported by up to 19.2 percent of people taking Myfortic. Other common side effects included:
 
(To learn more, click Myfortic Side Effects and Myfortic Warnings and Precautions. These articles talk in greater detail about the risks associated with this medication and what you can do to reduce your risk of problems.)
 
 
Written by/reviewed by: Susan Lakey, PharmD, MPH, BCPP
Last reviewed by: Kristi Monson, PharmD
 
Referring Pages Articles